Dupilumab Effective for Up to 1 Year in Teens With AD: Study

by Medscape • 2021/09/24 • 0 Comments

Efficacy remained steady at high levels at 52 weeks, and serious adverse effects were rare, extension trial finds.
Medscape Medical News